Wanjia Group Holdings (HKSE:00401) ROCE % : -3.05% (As of Sep. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Wanjia Group Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Wanjia Group Holdings's annualized ROCE % for the quarter that ended in Sep. 2023 was -3.05%.

Wanjia Group Holdings ROCE % Historical Data

The historical data trend for Wanjia Group Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanjia Group Holdings ROCE % Chart

Wanjia Group Holdings Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

-24.83

-6.03

-1.13

-28.12

3.18

Wanjia Group Holdings Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
ROCE %	Get a 7-Day Free Trial															1.76	-57.67	-1.67	8.47	-3.05

Wanjia Group Holdings ROCE % Calculation

Wanjia Group Holdings's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	4.473	/	( ( (191.818 - 45.468)	+	(173.448 - 38.074) )	/ 2 )
	=	4.473	/	( (146.35	+	135.374)	/ 2 )
	=	4.473	/	140.862
	=	3.18 %

Wanjia Group Holdings's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Mar. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Mar. 2023 )		(Q: Sep. 2023 )
	=	-3.988	/	( ( (173.448 - 38.074)	+	(175.272 - 49.143) )	/ 2 )
	=	-3.988	/	( ( 135.374	+	126.129 )	/ 2 )
	=	-3.988	/	130.7515
	=	-3.05 %

(1) Note: The EBIT data used here is two times the semi-annual (Sep. 2023) EBIT data.

Wanjia Group Holdings (HKSE:00401) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Wanjia Group Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Wanjia Group Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Wanjia Group Holdings (HKSE:00401) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Wanjia Group Holdings Ltd (HKSE:00401) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

25 Canton Road, Harbour City, Suite 1801, 18th Floor, Tower 1, The Gateway, Kowloon, Hong Kong, HKG

Website

https://www.wanjia-gp.com

Wanjia Group Holdings Ltd is an investment holding company. Along with its subsidiaries, the company operates in principal activities of Pharmaceutical wholesale and distribution business, and Hemodialysis treatment and consultancy service business. The company generates key revenue from the Hemodialysis treatment and consultancy service business.

Wanjia Group Holdings (HKSE:00401) Headlines

No Headlines